Clinical Trial Update: An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration [Phase 1]

View source ↗

Summary

This open-label Phase 1 study evaluated the absorption, metabolism, excretion, and mass balance of radiolabeled Androxal given as a single oral dose to healthy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Androxal (enclomiphene citrate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Secondary Hypogonadism | Phase 1 | Status: COMPLETED